Connex3 was the first 3D printer to simultaneously 3D-print multiple colours and materials.
Stratasys has been at the forefront of 3D printing innovation for more than 25 years. The efficiency and flexibility of the company’s 3D printing solutions complement traditional manufacturing and empower manufacturers to push the limits of medical development. Through using 3D printing systems, companies are able to reduce costs, streamline operations and accelerate time-to-market (TTM).
Quick design and tooling revisions for medical applications
The introduction of 3D printing aids the development of a variety of medical inventions, including a variety of anatomical models, clinical simulators, and medical devices.
At a fraction of the cost of machining, 3D printing encourages quicker design and tooling revisions, as well as more thorough testing. This enables medical clients to avoid expensive reworking of devices and pushes their products to the market faster.
Complex 3D model printing for the medical device industry
Stratasys’ 3D printing solutions allow for the development of complex models such as human anatomical structures that cannot be manufactured any other way.
The 3D printing system can help improve and accelerate the design of laboratory and medical equipment as well as enabling highly accurate models of bone and tissue for surgical planning or research.
Clients can also set aside the usual design-for-manufacturing constraints for parts that will be 3D printed such as jigs, fixtures and custom components.
Rapid medical prototyping and 3D printing
In just hours or days, users can print 3D parts, patterns, molds or tool masters directly from CAD data, and train production staff using the same processes and materials that will be used for mass production.
Being able to print tools and parts directly from digital files reduces waste and warehousing costs, and, by eliminating the usual lead times, customers can respond quickly to demand spikes, design changes or damaged tools.
With the use of Stratesys’ 3D printers, complex, high-requirement parts are produced faster with high-capacity material that can withstand a variety of sterilisation methods, including steam autoclaving, radiation and ethylene oxide.
3D printing for clinical trials and pilot commercialisation
The option of a short production run can be selected using the same procedures and resources as a mass-produced product. Clients can 3D-print smooth, accurate Digital ABS injection molds, tough polycarbonate forming patterns, detailed casting patterns, and 3D-printed components for their final product.
Improvement of clinical relevance with 3D printing
Prior to in-vivo evaluation, customers are able to validate device performance on patient-derived 3D-printed anatomical models.
Realistic, pathology-specific anatomy can guide development from early design parameters all the way through to statistical validation.
For any business enquiries, please contact the company via the enquiry form on this page.
The new Stratasys F123 Series is easy to operate and maintain for all levels of experience, and is adept at every prototyping stage, including concept verification, design validation, and functional performance.
For rugged prototypes that function like end products, manufacturing tools that deliver under pressure, and production parts built on-demand, Fortus 450mc 3D Printer sets a high bar for speed, performance and accuracy.
The Objet30 Prime is the only desktop 3D printer in the world that works with 12 materials and gives users specialised properties such as flexibility and biocompatibility.